| BioID | bio3464 |
| Name | EFAROXAN |
| ChEMBL ID | CHEMBL57895 |
| Molecular Formula | C13H16N2O |
| Molecular Weight | 216.28 |
| Molecular Weight (Monoisotopic) | 216.1263 |
| Type | Small molecule |
| Max Phase | Phase 2 |
| Target ID | Tar18 |
| Target Name | Serine/threonine-protein kinase cot (COT) |
| Synonyms | EFAROXAN|EFAROXANO|Efaroxan|NSC-759562 |
| Smiles | CCC1(C2=NCCN2)Cc2ccccc2O1 |
| Inchi | InChI=1S/C13H16N2O/c1-2-13(12-14-7-8-15-12)9-10-5-3-4-6-11(10)16-13/h3-6H,2,7-9H2,1H3,(H,14,15) |
| Inchi Key | RATZLMXRALDSJW-UHFFFAOYSA-N |
| Molecular Species | BASE |
| Targets | 16.0 |
| Bioactivities | 35.0 |
| Np Likeness Score | 0.39 |
| Records Key | ['efaroxan', 'efaroxan', '6', 'SID26751896', '1522', 'EFAROXAN', 'Efaroxan', 'SID170466438', 'SID90341026', 'SID104171150', 'SID144203690', 'COVC-3899329430'] |
| Records Name | ['2-(2-Ethyl-2,3-dihydro-benzofuran-2-yl)-4,5-dihydro-1H-imidazole', '2-(2-Ethyl-2,3-dihydro-benzofuran-2-yl)-4,5-dihydro-1H-imidazole (efaroxan)', 'efaroxane', 'SID26751896', None, 'EFAROXAN', 'Efaroxan', 'SID170466438', 'SID90341026', 'SID104171150', 'SID144203690', 'EFAROXAN'] |
| Withdrawn Flag | False |
| Orphan | 0 |